It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We aimed to identify blood gene expression patterns associated to psychopathological trajectories retrieved from a large community, focusing on the emergence and remission of general psychiatric symptoms. Hundred and three individuals from the Brazilian High-Risk Cohort Study (BHRCS) for mental disorders were classified in four groups according to Child Behavior Checklist (CBCL) total score at the baseline (w0) and after 3 years (w1): low–high (L–H) (N = 27), high–low (H–L) (N = 12), high–high (H–H) (N = 34) and low–low (L–L) groups (N = 30). Blood gene expression profile was measured using Illumina HT-12 Beadchips, and paired analyses comparing w0 and w1 were performed for each group. Results: 98 transcripts were differentially expressed comparing w0 and w1 in the L-H, 33 in the H–L, 177 in the H–H and 273 in the L–L. Of these, 66 transcripts were differentially expressed exclusively in the L–H; and 6 only in the H–L. Cross-Lagged Panel Models analyses revealed that RPRD2 gene expression at w1 might be influenced by the CBCL score at w0. Moreover, COX5B, SEC62, and NDUFA2 were validated with another technique and were also differentially regulated in postmortem brain of subjects with mental disorders, indicating that they might be important not only to specific disorders, but also to general psychopathology and symptoms trajectories. Whereas genes related to metabolic pathways seem to be associated with the emergence of psychiatric symptoms, mitochondrial inner membrane genes might be important over the course of normal development. These results suggest that changes in gene expression can be detected in blood in different psychopathological trajectories.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Universidade Federal de São Paulo (UNIFESP), LiNC - Interdisciplinary Laboratory of Clinical Neurosciences, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); Post-Graduation Program in Psychiatry and Medical Psychology, UNIFESP, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c); UNIFESP, Genetics Division, Department of Morphology and Genetics, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202)
2 Universidade Federal de São Paulo (UNIFESP), LiNC - Interdisciplinary Laboratory of Clinical Neurosciences, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); Post-Graduation Program in Psychiatry and Medical Psychology, UNIFESP, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c)
3 Universidade Federal de São Paulo (UNIFESP), LiNC - Interdisciplinary Laboratory of Clinical Neurosciences, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c); UNIFESP, Genetics Division, Department of Morphology and Genetics, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202)
4 Universidade Federal de São Paulo (UNIFESP), LiNC - Interdisciplinary Laboratory of Clinical Neurosciences, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); Post-Graduation Program in Psychiatry and Medical Psychology, UNIFESP, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); UNIFESP, Genetics Division, Department of Morphology and Genetics, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202)
5 Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Laboratorio de Citogenomica, Departamento de Patologia, Sao Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)
6 Hospital Sírio-Libanês, Centro de Oncologia Molecular, São Paulo, Brazil (GRID:grid.413471.4) (ISNI:0000 0000 9080 8521); Universidade de Sao Paulo (USP), Sao Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)
7 National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c); Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498)
8 Hospital Sírio-Libanês, Centro de Oncologia Molecular, São Paulo, Brazil (GRID:grid.413471.4) (ISNI:0000 0000 9080 8521)
9 Post-Graduation Program in Psychiatry and Medical Psychology, UNIFESP, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); Queen’s University, Kingston General Hospital and Providence Care Hospital, Department of Psychiatry, School of Medicine, Kingston, Canada (GRID:grid.410356.5) (ISNI:0000 0004 1936 8331); Queen’s University, Centre for Neuroscience Studies (CNS), Kingston, Canada (GRID:grid.410356.5) (ISNI:0000 0004 1936 8331)
10 Pontifical Catholic University of Rio Grande do Sul, Medicine and Medical Sciences Graduate Program, School of Medicine, Brain Institute (InsCer), Porto Alegre, Brazil (GRID:grid.412519.a) (ISNI:0000 0001 2166 9094)
11 National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c); Universidade Federal do Rio Grande do Sul (UFRGS), Laboratórios de TDAH e Psiquiatria do Desenvolvimento, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498)
12 National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c); FMUSP, Department of Psychiatry, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)
13 Post-Graduation Program in Psychiatry and Medical Psychology, UNIFESP, São Paulo, Brazil (GRID:grid.411249.b) (ISNI:0000 0001 0514 7202); National Institute of Developmental Psychiatry for Children and Adolescents (INPD), São Paulo, Brazil (GRID:grid.500696.c)